Skip to main content
Elvira Mass MagNet: Macrophage Niche Network Dynamics
© Brigitta Leber

News categories: Honors & Funding

The ‘choreographers’ of tissue development and function

The German Research Foundation (DFG) is setting up a new research group at the University of Bonn. ‘MagNet: Macrophage Niche Network Dynamics’ is dedicated to the systematic study of macrophages, specialised immune cells that play a central role in tissue development and function. The spokesperson of the research group is ImmunoSensation member Prof Dr Elvira Mass from the University of Bonn, supported by co-spokesperson Prof Dr Falk Nimmerjahn from Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).

Macrophages, are immune cells that can be found in every organ of the body. While research has so far focused on their role in connection with immune defence and inflammation, the new ‘MagNet’ research group is now looking at how macrophages act as ‘choreographers’ to control tissue development and function. This is because macrophages also significantly influence the development, regeneration and repair of tissues. However, systematic research into these fundamental functions has not yet been carried out. Using state-of-the-art methods such as single-cell analyses, imaging and computer-aided modelling, the team led by Prof. Elvira Mass from the LIMES Institute at the University of Bonn is investigating how macrophages interact with cells in their immediate environment - their so-called ‘niche network’ - and thereby ensure the functionality of organs. The scientists want to decipher both general and tissue-specific communication processes.

‘Detailed knowledge of how macrophages communicate with other cells and thereby ensure the functionality of organs could contribute in the long term to the development of new therapies for diseases in which tissue damage or dysfunction occurs,’ explains Prof Dr Elvira Mass, who is also spokesperson for the transdisciplinary research area “Life and Health”. These include chronic inflammation, autoimmune diseases and degenerative diseases.

Researchers from the fields of cell biology, developmental immunology and systems biology at ImmunoSensation2 at the University of Bonn, FAU, the University Medical Centre Hamburg-Eppendorf and the University of Freiburg are involved in the MagNet research group

 

Contact

Prof. Elvira Mass

LIMES Institute

University of Bonn

mail: elvira.mass@uni-bonn.de

 

Related news

Gut

News categories: Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

News categories: Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry
PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry

Back to the news overview